These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34530993)

  • 41. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
    Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF
    Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
    Ben Hassine I; Gharbi H; Soltani I; Ben Hadj Othman H; Farrah A; Amouri H; Teber M; Ghedira H; Ben Youssef Y; Safra I; Abbes S; Menif S
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):829-839. PubMed ID: 28836054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population.
    Dey S; Stalin S; Gupta A; Saha D; Kesh K; Swarnakar S
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E42-53. PubMed ID: 22121090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
    Guillem VM; Cervantes F; Martínez J; Alvarez-Larrán A; Collado M; Camós M; Sureda A; Maffioli M; Marugán I; Hernández-Boluda JC
    Am J Hematol; 2010 Jul; 85(7):482-6. PubMed ID: 20575039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential tumour suppressor role for caspase-9 (CASP9) in the childhood malignancy, neuroblastoma.
    Catchpoole DR; Lock RB
    Eur J Cancer; 2001 Nov; 37(17):2217-21. PubMed ID: 11677110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.
    Gao X; Li J; Wang L; Lin J; Jin H; Xu Y; Wang N; Zhao Y; Liu D; Yu L; Wang Q
    Am J Case Rep; 2016 Oct; 17():793-798. PubMed ID: 27784881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia.
    Delmond KA; Delleon H; Goveia RM; Teixeira TM; Abreu DC; Mello-Andrade F; Reis AADS; Silva DME; Barbosa ADP; Tavares RS; Anunciação CE; Silveira-Lacerda E
    Mol Biol Rep; 2021 Mar; 48(3):2035-2046. PubMed ID: 33709282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis.
    Singh M; Mastana S; Singh S; Juneja PK; Kaur T; Singh P
    Cytokine; 2020 Mar; 127():154985. PubMed ID: 31951965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms and haplotypes of the CYP2B6 detoxification gene in the predisposition of Acute Myeloid Leukemia (AML) and induction of its cytogenetic abnormalities.
    Daraki A; Kakosaiou K; Zachaki S; Sambani C; Aleporou-Marinou V; Kollia P; Manola KN
    Cancer Genet; 2016 Nov; 209(11):525-533. PubMed ID: 27865701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density.
    Ezura Y; Nakajima T; Kajita M; Ishida R; Inoue S; Yoshida H; Suzuki T; Shiraki M; Hosoi T; Orimo H; Emi M
    J Bone Miner Res; 2003 Sep; 18(9):1642-9. PubMed ID: 12968673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer.
    Yilmaz SG; Yencilek F; Yildirim A; Yencilek E; Isbir T
    In Vivo; 2017; 31(2):205-208. PubMed ID: 28358701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential requirement for caspase 9 in apoptotic pathways in vivo.
    Hakem R; Hakem A; Duncan GS; Henderson JT; Woo M; Soengas MS; Elia A; de la Pompa JL; Kagi D; Khoo W; Potter J; Yoshida R; Kaufman SA; Lowe SW; Penninger JM; Mak TW
    Cell; 1998 Aug; 94(3):339-52. PubMed ID: 9708736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
    Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
    Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia.
    Sailaja K; Surekha D; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(2):461-4. PubMed ID: 20843134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
    Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa I; Fundia A
    Blood Cells Mol Dis; 2016 Jul; 59():129-33. PubMed ID: 27282582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
    Ravandi F; Kantarjian HM; Talpaz M; O'Brien S; Faderl S; Giles FJ; Thomas D; Cortes J; Andreeff M; Estrov Z; Rios MB; Albitar M
    Cancer; 2001 Jun; 91(11):1964-72. PubMed ID: 11391574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.
    Kuida K; Haydar TF; Kuan CY; Gu Y; Taya C; Karasuyama H; Su MS; Rakic P; Flavell RA
    Cell; 1998 Aug; 94(3):325-37. PubMed ID: 9708735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine-N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients.
    Omran MM; Abdelfattah R; Moussa HS; Alieldin N; Shouman SA
    Front Oncol; 2020; 10():1348. PubMed ID: 32974132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.